Francois-Xavier Bouvignies from UBS retains his positive opinion on the stock with a Buy rating. Previously set at EUR 880, the target price has been raised to EUR 1050.
In a research note, UBS analyst Francois-Xavier Bouvignies has maintained his recommendation on the stock with a Buy rating. The target price is unchanged and still at EUR 46.